LMNTIC Biotech develops liquid biopsy technology to isolate rare tumor cells in blood LMNTIC Biotech pioneers novel ...
Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...
Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...
Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.
In a study involving 43 MBC patients, the liquid biopsy test reclassified three out of five patients who were initially deemed HER2-negative by tissue biopsy as HER2-positive. This discovery ...
PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with ...
The global cancer biopsy market is set to experience robust growth, with a market size of USD 25.5 billion in 2023, according ...
The World Health Organization's Global Cancer Observatory (GLOBOCAN) estimates that prostate cancer is a significant health concern for men in India. Hebert, et al reported that about 85 percent ...
BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leader in liquid biopsy tests for early cancer detection ...
The National on MSN7d
Abu Dhabi's new colon cancer blood test aims to boost early detection ratesAbu Dhabi health chiefs have hailed the introduction of a blood test for colon cancer as a "game-changer" in the emirate's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback